|
Merck & Co Earnings Call, Second Quarter 2008 |
| |
Author: Maclintosh Kuhlengisa
123jump.com
Last Update: 11:02 AM ET July 24 2008
Email Q&A | Print
Q&A
The pharmaceutical company reported earnings of $1.77 billion or 86 cents a share, up 5% over $1.68 billion or 77 cents a share in 2007, reflecting continued efforts to create a leaner, more cost effective and customer-focused operating model. Revenue was down 1%, to $6.05 billion from $6.1 billion in the prior year due to challenges to key brands, such as GARDASIL and SINGULAIR, and the continued impact of the loss of marketing exclusivity for FOSAMAX. |
|
| |
|
|